£19.0 m Proposed Placing, Subscription and Open Offer – Shield Therapeutics

Peel Hunt is acting as NOMAD, joint Bookrunner and joint Corporate Broker to Shield Therapeutics plc on its proposed equity fund raise of up to £19.0 m (by way of a subscription and placing of new ordinary shares to raise £15.1m in aggregate at a price of 6 pence per new ordinary share, together with an Open Offer of up to 64,346,927 new ordinary shares to raise up to £3.9 m), as announced on 13th December, 2022.